Anti-Melanogenesis Effect of Rosa rugosa on α-MSH-Induced B16F10 Cells via PKA/CREB Pathway Activation
Xianrong Zhou, Jung Hwan Oh, Fatih Karadeniz, Jiho Yang, Hyunjung Lee, Youngwan Seo, Chang‐Suk Kong
Abstract
Melanin protects the skin against UV damage, whereas excessive melanin accumulation causes abnormal pigmentation and even melanoma. It has been reported that Rosa rugosa exhibits antioxidant, anti-bacterial, anti-tumor, and anti-inflammation activities. The current study evaluated the melanogenesis-suppressing effect of R. rugosa extract and its solvent fractions (H2O, n-BuOH, 85% aq. MeOH, and n-hexane). The effect of R. rugosa on the extra/intra-cellular melanin and intracellular active tyrosinase levels, melanogenesis-related gene and protein expression, and PKA/CREB signaling pathway activation was investigated in α-MSH-induced B16F10 cells. The results showed that R. rugosa effectively suppressed melanin secretion and tyrosinase activity at non-cytotoxic concentrations. R. rugosa extract down-regulated the melanogenesis-related expression of genes and proteins of tyrosinase, microphthalmia-associated transcription factor (MITF), tyrosinase-related protein (TRP)-1, and TRP-2. Furthermore, R. rugosa effectively inhibited the phosphorylation of the PKA/CREB proteins. Finally, the total polyphenol content of R. rugosa crude extract and its H2O, n-BuOH, 85% aq. MeOH, and n-hexane solvent fractions were 1383.9 ± 44.5, 2004.7 ± 43.4, 7270.3 ± 54.5, 2064.1 ± 34.8, and 1091.1 ± 26.2 mg gallic acid equivalent/100 g extract, respectively. The anti-melanogenesis effect of R. rugosa was suggested to be exhibited by downregulating the PKA/CREB signaling pathway potentially due to a high content of polyphenols. Overall, R. rugosa crude extract and its solvent fractions could be considered sources of bioactive ingredients that can be used against hyperpigmentation.